User Guidance Clause Samples

The 'User guidance' clause outlines the responsibilities of a party to provide instructions, support, or information to users regarding the use of a product, service, or system. This may include supplying user manuals, offering training sessions, or maintaining a helpdesk to address user questions and issues. By ensuring users have access to necessary guidance, this clause helps prevent misuse, reduces errors, and enhances the overall user experience.
POPULAR SAMPLE Copied 1 times
User Guidance. ‌ The Active Learning System provide guidance on user input by two means: selecting the scene and selecting question type for user to contribute to. For the scenes, the goal is to ensure an even distribution among all scenes, excluding ones that will be reserved for testing. For question types, the goal is to encourage user to contribute more on the question types that: 1. annotated the least; 2. the model showed insufficient performance on. On the other hand, since continuously requesting the same scene and question type would result in bad user experience, the system make use of random generation with probability to ensure enough freshness in the user experience. Since the data set has abundant number of scenes available, for scene selection, we use an uniform distribution for the scenes which has least count of annotation: P (Si) =  Nmin Si = Smin  0 Si ƒ= Smin where Si denotes the count of annotation of Scene i, Smin denotes the the min of all Si and Nmin denotes | {Si | Si = Smin} |. For the question type selection, we start by defining the normalized question type count QˆiN = QiN , where QiN is the count of annotations on question type Qi and QN is the total count of annotations. f (Q) = 3 − (QˆiN + QiF1 + QiEM ) (3.2) P (Q) = c − 1 e3 − 1 × (e − 1) + 1 (3.3) f (Q) Here QiF1 and QiEM denotes the F-1 score and Exact Match for question type Qi and c is a scaling factor used to control the upper bound of the probability of a single question type. Since QiN , QiF1 and QiEM all have range [0, 1], f (Q) has range of [0, 3]. The exponential function will then have range of [1, e3]. The factor c scales the probability linearly range to [1, c]. It denotes the ratio of probability of a question type with minimal statistics being chose and one of an answer with maximal statistics being chose. The exponential function guarantees the discrepancy between low stat and high stat will rise rapidly while c ensures a question type with perfect statistics still have 1 chance of selected with respect to a question type with minimal statistics. The final probability is computed by normalizing P (Qi) for all question types. In order to prevent the side effect that revealing the test case statistics in user guidance could cause biases in our results, a set of data disjoint with the training data and test data is separated and used for obtaining statistics for user guidance purpose only. Here QiF1 and QiEM are the statistics from such dev data sets. The true exact matc...
View Source
User Guidance 
View Source

Related to User Guidance

  • ICO Guidance 6.1 The Parties agree to take account of any guidance issued by the Information Commissioner and/or any relevant central government body. The Buyer may on not less than thirty (30) Working Days’ notice to the Supplier amend the contract to ensure that it complies with any guidance issued by the Information Commissioner and/or any relevant central government body.

  • TECHNICAL GUIDANCE LETTERS In the sole discretion of the System Agency, and in conformance with federal and state law, the System Agency may issue instructions, clarifications, or interpretations as may be required during work performance in the form of a Technical Guidance Letter (TGL). A TGL must be in writing, and may be delivered by regular mail, electronic mail, or facsimile transmission. Any TGL issued by the System Agency will be incorporated into the Contract by reference for all purposes when it is issued.

  • Hot Weather Guidelines For the purposes of site based discussions regarding the need to plan and perform work during expected periods of hot weather, the following issues shall be considered in conjunction with proper consideration of Occupational Health and Safety issues.

  • Guidance This communications protocol will guide all planning, development and implementation of Communications Activities with a view to ensuring efficient, structured, continuous, consistent, and coordinated communications to the Canadian public.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.